Institutional & Family Asset Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-11
| Closed | -$335 | – | 764 |
|
|
2023
Q4 | $335 | Hold |
11
| – | – | ﹤0.01% | 683 |
|
|
2023
Q3 | $348 | Buy |
11
+6
| +120% | +$190 | ﹤0.01% | 681 |
|
|
2023
Q2 | $204 | Hold |
5
| – | – | ﹤0.01% | 730 |
|
|
2023
Q1 | $186 | Hold |
5
| – | – | ﹤0.01% | 712 |
|
|
2022
Q4 | $174 | Hold |
5
| – | – | ﹤0.01% | 698 |
|
|
2022
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 748 |
|
|
2022
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 767 |
|
|
2022
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 814 |
|
|
2021
Q4 | $1K | Hold |
5
| – | – | ﹤0.01% | 739 |
|
|
2021
Q3 | $1K | Sell |
5
-3
| -38% | -$600 | ﹤0.01% | 854 |
|
|
2021
Q2 | $1K | Buy |
+8
| New | +$1K | ﹤0.01% | 901 |
|